Urolithin A has attracted genuine scientific attention as a compound that supports mitochondrial health through a process called mitophagy: the cellular system for identifying and clearing out damaged mitochondria so healthier ones can replace them. Unlike many trending supplements, it has been tested in a small but growing number of randomized controlled trials, which gives consumers something concrete to evaluate before committing to a recurring monthly cost.
Whether ongoing supplementation is worthwhile is a genuinely complicated question. Urolithin A is not present in food directly; it depends on gut bacteria converting ellagitannins from pomegranates, walnuts, and berries, and many people lack the microbiome composition to produce meaningful amounts naturally. This article walks through what the trials actually measured, what they found, and the honest limitations you should weigh before subscribing.
Key Takeaways
- Urolithin A activates mitophagy, the cellular removal of damaged mitochondria, a process central to its proposed benefits that slows naturally with age.
- Multiple randomized controlled trials have confirmed the compound is well tolerated, with no serious adverse events reported in studies ranging from healthy adults to heart failure patients [1][2].
- Clinical trials in athletes are small and mixed: one reported more repetitions to failure but, by its authors’ own statement, no improved muscle strength, and a distance-runner trial found no significant improvement in 3000 m time [3][4], so athletic performance is not an established use case for ongoing supplementation [3][4][6].
- A 2025 randomized controlled trial found evidence relevant to age-related immune decline [5]; the trial tested 50 healthy middle-aged adults for 4 weeks and found very small shifts in immune cell subsets, so it does not establish a rationale for long-term use [5].
- Most trials are short (4 weeks to 4 months) [9][10] and conducted in specific populations; effects in the general public over years of use, and optimal dosing, remain areas of active research.
How Urolithin A Works: Mitophagy in Plain Language
Mitochondria are the energy-producing structures inside every cell. Over time they accumulate damage and become less efficient. Mitophagy is the cellular housekeeping process that tags these dysfunctional mitochondria for removal, allowing the cell to replace them with newer, better-functioning versions. This process naturally slows with age, which is one reason cellular energy output tends to decline as we get older.
Urolithin A appears to stimulate mitophagy by activating signaling pathways that prompt cells to clear damaged mitochondria more actively. A 2019 first-in-human study reported that oral supplementation had a favourable safety profile and changed plasma and muscle markers; these are biomarker signals rather than proof of clinical benefit [1]. That foundational safety and mechanism finding has supported the subsequent generation of trials testing whether those molecular changes translate into meaningful real-world outcomes.
Safety and Tolerability: The Prerequisite for Any Subscription
Any discussion of a subscription supplement should begin with safety. The first human clinical trial established that urolithin A was well tolerated across doses and produced a molecular signature of improved mitochondrial and cellular health without serious adverse events [1]. That study examined healthy older adults over four weeks and laid the groundwork for larger trials.
Research note: In an 8-week trial in 20 resistance-trained men, the 1RM bench press and squat gains versus placebo (+3.50 kg and +2.55 kg) did not reach statistical significance (p = 0.462 and p = 0.710) [3].
Subsequent trials in more diverse populations, including heart failure patients [2] and athletes undergoing intense training blocks [6][3]have not raised new safety concerns. That said, individual trials have run from four weeks to four months [9][10], and no multi-year safety dataset in humans has been published. This is worth factoring in if you are considering indefinite supplementation.
Muscle Performance and Physical Recovery
Several trials have specifically examined how urolithin A supplementation affects physical performance: a logical application given that mitochondrial function underlies aerobic capacity and muscle recovery. An 8-week randomized, double-blind, placebo-controlled study in male athletes performing resistance training assessed effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism [3].
The longest trials ran about four months, in 88 middle-aged and 66 older adults. Both were funded by Amazentis and both missed their primary endpoints, with some secondary measures favouring urolithin A [9][10].
A pilot randomized controlled trial in academy soccer players during preseason evaluated supplementation’s impact on performance and antioxidant status [6]. A separate study in highly trained male distance runners examined running performance, recovery, and mitochondrial biomarkers [4]. These trials are small and mixed: the runners trial found no significant improvement in 3000 m time, the resistance trial’s authors state it did not show improved strength, and the 20-player soccer pilot reported a wide confidence interval on its primary endpoint [3][4][6], though most participants were trained athletes rather than the general sedentary adult population, so how well the findings generalize is an open question.
For someone whose primary motivation for subscribing is athletic recovery or endurance performance, the evidence is thin: the athlete trials are small (20 to 42 participants) and mostly did not improve performance measures [3][4][6]. For someone with no regular training habit, the same trial data does not directly apply.
Immune Health and Aging: A Long-Term Rationale
One recent trial addresses immune function, with very small effects [5]. A randomized, placebo-controlled trial published in Nature Aging in 2025 examined the effect of urolithin A on age-related immune decline [5]. The aging immune system, sometimes called immunosenescence, is partly tied to mitochondrial dysfunction in immune cells, making mitophagy stimulation a plausible biological mechanism.
This trial is particularly relevant to the subscription question because immune health is an ongoing need rather than a short-term goal. Unlike a brief course of antibiotics for an infection, whether supporting the mitochondrial health of immune cells requires continued supplementation has not been tested [5]. In the 28-day trial of 50 healthy middle-aged adults, the fraction of naive-like CD8+ T cells rose by 0.50 percentage points versus placebo, a very small shift, and the trial was funded by Amazentis [5].
Cardiovascular and Emerging Research: What the Evidence Does and Does Not Say
Researchers have begun exploring urolithin A in cardiovascular contexts. A randomized, double-blind, crossover, placebo-controlled clinical trial evaluated its effects in heart failure patients with reduced ejection fraction [2]. It was negative: across two four-week periods at 500 mg twice daily, urolithin A produced no significant change in ejection fraction or other echocardiographic measures, and none in pro-BNP, glucose or CRP. So while the compound has now been tested in a serious medical population, that test did not show a cardiac benefit, and heart failure requires physician-directed treatment, with supplementation in this context never self-managed.
Preclinical animal studies have examined urolithin A in diabetic cardiomyopathy via SIRT1 activation in rats [7] and in an ALS mouse model looking at motor dysfunction via mitophagy pathways [8]. Animal studies can illuminate mechanisms and guide future human trial design, but they do not establish that the same effects occur in people at supplementation doses. These findings are exploratory and should not serve as reasons to subscribe if your goal is to address a specific cardiovascular or neurological condition.
The Honest Cost-Benefit Calculation
Urolithin A supplements, particularly the clinically studied bioavailable form, sit at the expensive end of the supplement market. A subscription lowers per-unit cost but still represents a meaningful recurring expense. Whether that is justified depends heavily on what you are hoping to achieve and how closely your circumstances match the populations studied in trials.
The strongest human evidence currently exists for markers of mitochondrial and cellular health in healthy adults [1], muscle performance in small athlete trials with mixed results [3][4][6], and age-related immune decline [5]. If your goal falls into one of these categories, the evidence is at least coherent, though no trial to date has demonstrated reversal of disease or lifespan extension in humans.
If your motivation is to address a diagnosed medical condition (heart failure, diabetes-related complications, or a neurological condition) the existing human evidence is either very limited or primarily from animal models. In those situations, consulting a physician before and instead of self-prescribing a supplement subscription is the appropriate path.
🛒 Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day: The clinically studied form (Amazentis); used in the human trials. - Pure Encapsulations Renual
caplique capsules, 250 mg Mitopure Urolithin A/serving (with resveratrol + CoQ10): adds resveratrol and CoQ10, a combination the published urolithin A trials did not test. - ProHealth Longevity Urolithin A
capsules, 500 mg: Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg: Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
Most clinical trials on urolithin A have been short in duration (4 weeks to 4 months) [9][10] and conducted in specific populations such as trained athletes or adults with particular health conditions; long-term effects and generalizability to all adults are not yet fully established. If you have a chronic illness, take prescription medications, or are pregnant or breastfeeding, consult a qualified healthcare provider before adding any supplement to your routine.
Frequently Asked Questions
Why take urolithin A as a subscription rather than a short course?
Mitophagy is a continuous cellular maintenance process, not a one-time repair job. The biological rationale for ongoing supplementation is that the compound needs to be consistently present to sustain its mitophagy-stimulating effect. Clinical trials showing molecular changes in mitochondrial health measured outcomes over weeks of continuous use [1], and athletic performance trials ran 8 weeks or longer [3], although neither the 8-week athlete trial nor the 4-week runners trial showed a clear performance gain [3][4].
What does the evidence say about urolithin A and muscle function?
An 8-week randomized, double-blind, placebo-controlled study in male athletes performing resistance training examined effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism [3]. A separate study in highly trained male distance runners assessed running performance, recovery, and mitochondrial biomarkers [4]. Both trials were conducted in trained athletes, so how well findings apply to less active adults is not directly established by this evidence.
Is urolithin A safe to take long-term?
Published trials across multiple populations (healthy older adults, trained athletes, and heart failure patients) have not identified serious safety concerns at the doses studied [1][6][2]. However, the longest individual trials run about four months [9][10], and no multi-year safety dataset in humans has been published. Anyone with a chronic health condition or taking prescription medications should discuss supplementation with a physician before starting.
Can urolithin A help with immune aging?
A randomized, placebo-controlled trial published in Nature Aging in 2025 specifically examined the effect of urolithin A on age-related immune decline [5]. Immune cell mitochondrial function is tied to immune competence, making mitophagy stimulation a plausible mechanism. This was a 4-week trial in 50 healthy middle-aged adults with very small effects, so it adds little to the case for long-term use in older adults [5], though it does not establish that supplementation prevents any specific disease.
Why can't I just eat more pomegranates instead of subscribing?
Urolithin A is not found in food itself: it is produced by gut bacteria that convert ellagitannins from pomegranates, walnuts, and berries. A substantial portion of the population lacks the specific microbial composition needed to produce clinically relevant amounts from diet alone. Direct oral supplementation bypasses this individual variability, which is why clinical trials have used supplements rather than dietary interventions to achieve consistent dosing.
Is there human evidence for urolithin A in heart disease?
A randomized, double-blind, crossover, placebo-controlled clinical trial evaluated urolithin A specifically in heart failure patients with reduced ejection fraction [2]. It was a trial of only 10 patients and found no significant change in heart function; the authors say the results do not support a benefit [2]. Heart failure is a serious medical condition requiring physician-supervised care, and supplementation in this population should only occur under medical supervision: it should never substitute for prescribed treatments.
References
- Andreux PA et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature metabolism (2019). PMID 32694802
- Jamialahmadi T et al. Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial. Reviews on recent clinical trials (2024). PMID 38415449
- Zhao H et al. Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training: an 8-week randomized, double-blind, placebo-controlled study. Journal of the International Society of Sports Nutrition (2024). PMID 39487653
- Whitfield J et al. Evaluating the Impact of Urolithin A Supplementation on Running Performance, Recovery, and Mitochondrial Biomarkers in Highly Trained Male Distance Runners. Sports medicine (Auckland, N.Z.) (2025). PMID 40839339
- Denk D et al. Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nature aging (2025). PMID 41174221
- Monsalve Acevedo A et al. Effects of Urolithin A supplementation on performance and antioxidant status in academy soccer players during preseason: a pilot randomised controlled trial. Frontiers in nutrition (2025). PMID 41245402
- Albasher G et al. Urolithin A prevents streptozotocin-induced diabetic cardiomyopathy in rats by activating SIRT1. Saudi journal of biological sciences (2022). PMID 35241966
- Zhang H et al. Urolithin a Improves Motor Dysfunction Induced by Copper Exposure in SOD1(G93A) Transgenic Mice Via Activation of Mitophagy. Molecular neurobiology (2025). PMID 39292338
- Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell reports. Medicine (2022). PMID 35584623
- Liu S et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA network open (2022). PMID 35050355
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.